Modelling the impact of tailored behavioural interventions on chlamydia transmission.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 01 2021
Historique:
received: 21 07 2020
accepted: 07 01 2021
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 18 9 2021
Statut: epublish

Résumé

Behavioural interventions tailored to psychological characteristics of an individual can effectively achieve risk-reducing behaviour. The impact of tailored interventions on population-level chlamydia prevalence is unknown. We aimed to assess the impact on overall chlamydia prevalence five years after the introduction of an intervention aimed at increasing self-efficacy, social norms, attitudes and intentions towards condom use (i.e., condom intervention), and an intervention aimed at increasing health goals and decreasing impulsiveness (i.e., impulsiveness intervention). A pair model, informed by longitudinal psychological and behavioural data of young heterosexuals visiting sexual health centers, with susceptible-infected-susceptible structure was developed. The intervention effect was defined as an increased proportion of each subgroup moving to the desired subgroup (i.e., lower risk subgroup). Interventions tailored to subgroup-specific characteristics, assuming differential intervention effects in each subgroup, more effectively reduced overall chlamydia prevalence compared to non-tailored interventions. The most effective intervention was the tailored condom intervention, which was assumed to result in a relative reduction in chlamydia prevalence of 18% versus 12% in the non-tailored scenario. Thus, it is important to assess multiple psychological and behavioural characteristics of individuals. Tailored interventions may be more successful in achieving risk-reducing behaviour, and consequently, reduce chlamydia prevalence more effectively.

Identifiants

pubmed: 33495513
doi: 10.1038/s41598-021-81675-w
pii: 10.1038/s41598-021-81675-w
pmc: PMC7835240
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2148

Références

Aust N Z J Public Health. 2005 Jun;29(3):254-60
pubmed: 15991774
BMC Infect Dis. 2018 Nov 13;18(1):559
pubmed: 30424737
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Am J Epidemiol. 2019 Sep 1;188(9):1705-1712
pubmed: 31145447
Epidemics. 2019 Sep;28:100337
pubmed: 31126778
Lancet Infect Dis. 2016 Sep;16(9):1057-1064
pubmed: 27289389
J Adolesc Health. 2005 Jul;37(1):69-74
pubmed: 15963909
Sex Transm Infect. 2019 Jun;95(4):300-306
pubmed: 30606817
Sci Rep. 2015 Oct 28;5:15411
pubmed: 26507957
J Adolesc Health. 2007 Jun;40(6):573.e1-6
pubmed: 17531767
Lancet Infect Dis. 2017 Aug;17(8):e235-e279
pubmed: 28701272
Sex Transm Infect. 2013 Feb;89(1):57-62
pubmed: 22683893
J Sex Res. 2018 Jan;55(1):45-59
pubmed: 27982710
Sex Transm Infect. 2002 Oct;78(5):334-8
pubmed: 12407233
Epidemics. 2010 Sep;2(3):123-131
pubmed: 21352783
PLoS One. 2013;8(3):e58674
pubmed: 23527005
Sex Transm Dis. 2020 Mar;47(3):171-176
pubmed: 31876886
J Adolesc Health. 2010 Jul;47(1):12-9
pubmed: 20547287
Stat Commun Infect Dis. 2012 Nov 1;4(1):
pubmed: 24058722
Health Educ Res. 2000 Jun;15(3):339-52
pubmed: 10977381
J Theor Biol. 2013 Nov 21;337:125-32
pubmed: 23988796
Clin Infect Dis. 2018 Jan 18;66(3):437-443
pubmed: 29136127
Prev Med. 2016 Oct;91:364-382
pubmed: 27373209
J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55
pubmed: 20470050
BMC Public Health. 2016 Jan 20;16:55
pubmed: 26790411
Sex Transm Dis. 2012 Feb;39(2):92-6
pubmed: 22249296
Sex Transm Dis. 2015 Mar;42(3):109-14
pubmed: 25668640
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
Arch Sex Behav. 2014 May;43(4):659-67
pubmed: 24081445
J Adolesc Health. 2002 Apr;30(4):229-32
pubmed: 11927234
Sex Transm Infect. 2020 Feb;96(1):26-32
pubmed: 31350380
Epidemiol Infect. 2011 Dec;139(12):1875-83
pubmed: 21299913
AIDS. 2003 May 2;17(7):1029-38
pubmed: 12700453
Sex Transm Dis. 2017 May;44(5):278-283
pubmed: 28407643
Epidemiology. 2013 Nov;24(6):854-62
pubmed: 24076992
Sci Rep. 2019 May 17;9(1):7547
pubmed: 31101863
Sex Transm Infect. 2019 Feb;95(1):53-59
pubmed: 29925670
Stat Med. 2013 Apr 30;32(9):1547-60
pubmed: 22949217
J R Soc Interface. 2010 Sep 6;7(50):1247-56
pubmed: 20504800
Int J STD AIDS. 2016 Apr;27(5):333-48
pubmed: 26608577
Ann Intern Med. 2014 Dec 16;161(12):894-901
pubmed: 25244227
BMC Infect Dis. 2017 Dec 20;17(1):782
pubmed: 29262776
BMC Public Health. 2010 Nov 24;10:725
pubmed: 21106064
J R Soc Interface. 2018 Apr;15(141):
pubmed: 29618527
Perspect Sex Reprod Health. 2009 Dec;41(4):225-30
pubmed: 20444177
Sex Reprod Healthc. 2011 Jan;2(1):13-20
pubmed: 21147454
J Adolesc Health. 2004 Jan;34(1):3-26
pubmed: 14706401
J Sex Res. 2013;50(5):480-8
pubmed: 22456443
Am J Epidemiol. 1996 Aug 1;144(3):306-17
pubmed: 8686700
BMJ. 2012 Jul 05;345:e4316
pubmed: 22767614
Prev Med. 2020 Oct;139:106200
pubmed: 32659244
Sci Rep. 2015 Apr 22;5:9467
pubmed: 25902018

Auteurs

Daphne A van Wees (DA)

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. daphne.van.wees@rivm.nl.

Chantal den Daas (C)

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.
Department of Interdisciplinary Social Science, Faculty of Social and Behavioural Sciences, Utrecht University, Utrecht, The Netherlands.

Mirjam E E Kretzschmar (MEE)

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Janneke C M Heijne (JCM)

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH